Related Experiment Videos
cAMP detection methods in HTS: selecting the best from the rest.
1Hit Discovery Group, Pfizer Global Research and Development, Ramsgate Road, Sandwich, Kent CT13 9NJ, UK. chris_williams@sandwich.pfizer.com
Nature Reviews. Drug Discovery
|March 26, 2004
Summary
Choosing high-throughput screening technologies for G-protein-coupled receptors, especially Gi/Gs types, is challenging. This review covers cyclic AMP detection systems for drug discovery, noting future needs for richer biological data.
Area of Science:
- Pharmacology
- Biochemistry
- Molecular Biology
Background:
- High-throughput screening (HTS) technologies for G-protein-coupled receptors (GPCRs) have rapidly advanced.
- Selecting appropriate HTS technologies, particularly for Gi- and Gs-coupled receptors, presents a significant challenge.
- Cyclic AMP (cAMP) detection is a common readout for GPCR functional screening.
Purpose of the Study:
- To review common cyclic AMP detection systems used in HTS for GPCRs.
- To highlight practical and theoretical considerations for applying these systems.
- To assess the current state and future directions of HTS technologies for GPCRs.
Main Methods:
- Review of existing literature on cAMP detection assays for GPCRs.
- Analysis of practical and theoretical aspects of various HTS technologies.
- Discussion of limitations and future requirements for GPCR functional screening.
Main Results:
- Several common systems for cAMP detection are available for HTS.
- Each system has specific practical and theoretical advantages and disadvantages.
- Current technologies are functional but may lack comprehensive biological information.
Conclusions:
- The landscape of HTS technologies for GPCRs is diverse and evolving.
- Careful consideration of assay parameters is crucial for successful implementation.
- Future HTS technologies should aim to provide deeper biological insights for GPCR research.